KaloBios Pharmaceuticals (NASDAQ:KBIO)

CAPS Rating: 4 out of 5

Recs

0
Player Avatar fatmoneyrz (97.62) Submitted: 9/20/2013 10:19:48 PM : Outperform Start Price: $5.72 KBIO Score: -91.30

Some real nice catalysts upcoming, yet the stock has sold off recently. Cash position secure, and super cheap on a valuation basis. I expect some significant upside in the near-term.

Featured Broker Partners


Advertisement